TTK Healthcare Ltd
TTKHLTCARE NSE
TTK Healthcare Ltd
DiversifiedNSE: TTKHLTCARE BSE: 507747 Diversified Group
Key Fundamentals
MicrocapDiversified GroupDiversifiedMarket Cap
₹1,536 Cr
Volatility
Moderate
P/E Ratio
20.83
EBITDA
₹98.30 Cr
Return on Equity
5.89%
Debt to Equity
0.02
Book Value
₹785.85
EPS
₹44.94
52W High
₹1,216.8
52W Low
₹735
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TTK Healthcare Ltd insights
31 extracted metrics + investor summaries across FY08–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.4%
Weaknesses
3- Company has a low return on equity of 6.54% over last 3 years.
- Earnings include an other income of Rs.66.9 Cr.
- Working capital days have increased from 86.1 days to 161 days
Growth Rate
Revenue Growth
6.50% ↘
Net Income Growth
-19.58% ↘
Cash Flow Change
-431.41% ↘
ROE
-23.21% ↘
ROCE
-26.94% ↘
EBITDA Margin (Avg.)
-12.99% ↘
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 186 | 184 | 181 | 208 | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 |
| Expenses | 192 | 176 | 179 | 169 | 201 | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 |
| Operating Profit | 10 | 10 | 5 | 12 | 7 | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 |
| OPM % | 5% | 5% | 2.9% | 7% | 3.3% | 4.2% | 3.8% | 6% | 1.2% | 2.6% | 3.4% | 5% | 6% |
| Other Income | 15 | 16 | 16 | 16 | 37 | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PBT | 21 | 22 | 18 | 24 | 41 | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 |
| Tax % | 24% | 26% | 27% | 25% | 23% | 26% | 26% | 26% | 26% | 4% | 25% | 26% | 26% |
| Net Profit | 16 | 16 | 13 | 18 | 32 | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 |
| EPS in Rs | 11.09 | 11.33 | 9.12 | 12.93 | 22.35 | 12.17 | 11.84 | 11.43 | 9.2 | 14.43 | 7.45 | 15.4 | 15.06 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 519 | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | 888 |
| Expenses | 453 | 478 | 489 | 535 | 578 | 617 | 457 | 577 | 694 | 715 | 767 | 831 | 850 |
| Operating Profit | 30 | 40 | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 | 38 |
| OPM % | 6% | 8% | 7% | 7% | 8% | 4.4% | 4.1% | 3.6% | 4.3% | 5% | 4.3% | 3% | 4.3% |
| Other Income | 7 | 6 | 6 | 8 | 8 | 9 | 28 | 42 | 643 | 63 | 85 | 68 | 67 |
| Interest | 4 | 3 | 3 | 5 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 7 | 12 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 8 | 9 | 9 |
| PBT | 26 | 36 | 29 | 30 | 39 | 19 | 32 | 48 | 657 | 84 | 108 | 83 | 94 |
| Tax % | 39% | 36% | 36% | 40% | 38% | 37% | -44% | 13% | 3% | 25% | 25% | 20% | — |
| Net Profit | 16 | 23 | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS in Rs | 20.81 | 29.19 | 24.13 | 12.86 | 17.25 | 8.72 | 32.87 | 29.43 | 453 | 44.47 | 57.79 | 46.48 | 52.34 |
| Div. Payout % | 22% | 17% | 21% | 39% | 29% | 34% | 18% | 34% | 2% | 22% | 17% | 22% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 110 | 128 | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| Borrowings | 42 | 38 | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 |
| Other Liabilities | 115 | 128 | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 |
| Total Liabilities | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| Fixed Assets | 52 | 106 | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 |
| CWIP | 46 | 1 | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 0 | 10 | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| Other Assets | 177 | 185 | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 |
| Total Assets | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 39 | 37 | 18 | 25 | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 |
| Investing | -49 | -27 | 5 | -22 | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 |
| Financing | 3 | -11 | -23 | -7 | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 |
| Net Cash Flow | -7 | 0 | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free Cash Flow | -10 | 21 | 12 | 21 | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
| CFO/OP | 176 | 122 | 67 | 84 | 62 | 108 | 391 | 248 | -28 | 54 | 68 | -31 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory Days | 62 | 66 | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days Payable | 50 | 53 | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash Conversion Cycle | 46 | 46 | -11 | -16 | 22 | 23 | -2 | 1 | 19 | 36 | 43 | 63 |
| Working Capital Days | -31 | -38 | -24 | -30 | -6 | -3 | -32 | -28 | 4 | 49 | 48 | 161 |
| ROCE % | 20% | 23% | 18% | 15% | 15% | 8% | 6% | 8% | 10% | 9% | 9% | 8% |
Documents
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026. 2 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026.
4
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
27 Jan - Appointment of Mr V Sundaresan as Independent Director for five-year term effective December 22, 2025; resolution carried. 27 Jan - Appointment of Mr V Sundaresan as Independent Director for five-year term effective December 22, 2025; resolution carried.
5
Announcement under Regulation 30 (LODR)-Change in Management
2 Feb - Mr. N Ramesh Rajan completed second and final term; ceased as Independent Director effective Feb 03, 2026. 2 Feb - Mr. N Ramesh Rajan completed second and final term; ceased as Independent Director effective Feb 03, 2026.
Frequently Asked Questions about TTK Healthcare Ltd
What does TTK Healthcare Ltd do?
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1]
It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]
Where is TTK Healthcare Ltd (TTKHLTCARE) listed?
TTK Healthcare Ltd is listed on the Indian stock exchanges. It is listed on NSE: TTKHLTCARE and BSE: 507747. You can view its live share price, financials, and ratios on Tapetide.
Which sector does TTK Healthcare Ltd belong to?
TTK Healthcare Ltd operates in the Diversified sector within the Diversified Group industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of TTK Healthcare Ltd?
TTK Healthcare Ltd has a market capitalisation of approximately ₹1536.25 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of TTK Healthcare Ltd?
The Price-to-Earnings (PE) ratio of TTK Healthcare Ltd is 20.83. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of TTK Healthcare Ltd?
Over the past 52 weeks, TTK Healthcare Ltd has traded between a low of ₹735 and a high of ₹1,216.8. This range helps investors understand the stock's price volatility and recent trading levels.
Does TTK Healthcare Ltd pay dividends?
Yes, TTK Healthcare Ltd has a dividend yield of 0.90%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of TTK Healthcare Ltd?
TTK Healthcare Ltd has a Return on Equity (ROE) of 5.89%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research TTK Healthcare Ltd on Tapetide?
On Tapetide, you can view TTK Healthcare Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1] It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]
Website ttkhealthcare.com
CEO Mr. T. T. Raghunathan B.Com.
Employees 1,339
Listed 2015-12-02
Face Value ₹ 10
Issued Size 1,41,30,333